Robillard, L;
Nguyen, M;
Loehr, A;
Orsulic, S;
Kristeleit, RS;
Lin, K;
Raponi, M;
... Simmons, AD; + view all
(2017)
Preclinical evaluation of the PARP inhibitor rucaparib in combination with PD-1 and PD-L1 inhibition in a syngeneic BRCA1 mutant ovarian cancer model.
Presented at: AACR Annual Meeting 2017, Washington, D.C., USA.
Preview |
Text
Kristeleit_Preclinical evaluation of the PARP inhibitor rucaparib in combination with PD.pdf Download (327kB) | Preview |
| Type: | Conference item (Presentation) |
|---|---|
| Title: | Preclinical evaluation of the PARP inhibitor rucaparib in combination with PD-1 and PD-L1 inhibition in a syngeneic BRCA1 mutant ovarian cancer model |
| Event: | AACR Annual Meeting 2017 |
| Location: | Washington, D.C., USA |
| Dates: | 01 - 05 April 2017 |
| Open access status: | An open access version is available from UCL Discovery |
| Publisher version: | https://doi.org/10.1158/1538-7445.AM2017-3650 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1553486 |
Archive Staff Only
 |
View Item |
